Literature DB >> 20661222

MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification.

J A L Brown1, E Bourke, C Liptrot, P Dockery, C G Morrison.   

Abstract

Microcephalin (MCPH1/BRIT1) is a potential tumour suppressor that localizes to the centrosome, forms ionizing radiation-induced nuclear foci (IRIF) and is involved in the DNA damage checkpoints that ensure genome stability. Here, we report the impact of Mcph1 disruption in the hyper-recombinogenic DT40 cell line. Mcph1(-/-) cells were viable and proliferated at the same rate as wild-type controls. Mcph1-deficient cells had intact G2-to-M checkpoint responses after ionizing radiation (IR) treatment, but showed moderate radiosensitivity. Light and electron microscopy indicated normal centrosome structures in Mcph1 null cells, but IR induced massive amplification of centrosome numbers in the absence of Mcph1. Mcph1 null cells formed γ-H2AX and Rad51 IRIF, but resolved them more slowly than wild-type cells. Mcph1 deficiency caused sustained Chk1 phosphorylation after IR, dysregulating Cdk2 activity. These findings show that Mcph1 controls centrosome numbers after DNA damage, which may indicate a novel tumour suppressive mechanism for microcephalin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661222     DOI: 10.1038/onc.2010.302

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

Review 1.  Cdk5rap2 exposes the centrosomal root of microcephaly syndromes.

Authors:  Timothy L Megraw; James T Sharkey; Richard S Nowakowski
Journal:  Trends Cell Biol       Date:  2011-05-31       Impact factor: 20.808

Review 2.  Centrosomes in the DNA damage response--the hub outside the centre.

Authors:  Lisa I Mullee; Ciaran G Morrison
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

3.  MCPH1 is essential for cellular adaptation to the G2-phase decatenation checkpoint.

Authors:  María Arroyo; Ryoko Kuriyama; Israel Guerrero; Daniel Keifenheim; Ana Cañuelo; Jesús Calahorra; Antonio Sánchez; Duncan J Clarke; J Alberto Marchal
Journal:  FASEB J       Date:  2019-04-09       Impact factor: 5.191

4.  MCPH1 patient cells exhibit delayed release from DNA damage-induced G2/M checkpoint arrest.

Authors:  Ioannis Gavvovidis; Charlotte Pöhlmann; Juan Alberto Marchal; Markus Stumm; Daisuke Yamashita; Tatsuya Hirano; Detlev Schindler; Heidemarie Neitzel; Marc Trimborn
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

5.  BRCT-domain protein BRIT1 influences class switch recombination.

Authors:  Wei-Feng Yen; Ashutosh Chaudhry; Bharat Vaidyanathan; William T Yewdell; Joseph N Pucella; Rahul Sharma; Yulong Liang; Kaiyi Li; Alexander Y Rudensky; Jayanta Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-19       Impact factor: 11.205

Review 6.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

7.  Promoter hijack reveals pericentrin functions in mitosis and the DNA damage response.

Authors:  Yifan Wang; Tiago J Dantas; Pierce Lalor; Peter Dockery; Ciaran G Morrison
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

8.  BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1.

Authors:  Jianqiu Zou; Deli Zhang; Guang Qin; Xiangming Chen; Hongmin Wang; Dong Zhang
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  The E3 ubiquitin ligase APC/CCdh1 degrades MCPH1 after MCPH1-βTrCP2-Cdc25A-mediated mitotic entry to ensure neurogenesis.

Authors:  Xiaoqian Liu; Wen Zong; Tangliang Li; Yujun Wang; Xingzhi Xu; Zhong-Wei Zhou; Zhao-Qi Wang
Journal:  EMBO J       Date:  2017-11-17       Impact factor: 11.598

10.  Mitotic entry upon Topo II catalytic inhibition is controlled by Chk1 and Plk1.

Authors:  Maria Arroyo; Ana Cañuelo; Jesús Calahorra; Florian D Hastert; Antonio Sánchez; Duncan J Clarke; J Alberto Marchal
Journal:  FEBS J       Date:  2020-03-20       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.